Bayer’s $7.25B Roundup Settlement: What You Need to Know

For years, people who developed cancer after using Roundup weedkiller have fought a relentless legal battle against agricultural giant Monsanto, and its parent company, Bayer. After thousands of individual lawsuits and massive jury verdicts, the legal landscape is taking a significant turn. On March 4, 2026, the 22nd Judicial Circuit Court of Missouri granted preliminary approval for a proposed $7.25 billion class-action settlement.

If you or a loved one used Roundup and later developed non-Hodgkin’s lymphoma, this legal development directly impacts your rights. The proposed settlement aims to resolve current claims and future cases for the next 16 years. However, joining a class-action settlement is a major legal decision that requires careful consideration.

At Walch Law, we want to ensure you have the facts. This comprehensive guide explains the details of the $7.25 billion Roundup settlement, breaks down the eligibility requirements, outlines potential payouts, and highlights the urgent deadlines you must meet to protect your right to compensation.

The $7.25 Billion Class Settlement Explained

The Roundup litigation is one of the largest mass tort events in United States history. When Bayer acquired Monsanto in 2018, it inherited tens of thousands of lawsuits from individuals who claimed the glyphosate-based herbicide caused their cancer.

After 18 months of intense negotiations with a neutral mediator, attorneys representing a proposed class of victims reached a $7.25 billion agreement with Bayer. When attorneys filed the paperwork on February 17, 2026, it marked a potential turning point for thousands of pending claims.

Judge Timothy Boyer of the Missouri court granted preliminary approval for the plan, noting the substantial effort and financial commitment involved. The push for this settlement was heavily influenced by the U.S. Supreme Court’s January 2026 decision to hear a related case, Monsanto v. Durnell. Plaintiffs’ attorneys realized that a Supreme Court ruling in Monsanto’s favor could potentially dismiss or limit current and future claims. The settlement agreement seeks to eliminate that uncertainty, providing a guaranteed fund for victims.

Who Is Eligible for the Roundup Settlement?

To receive compensation from this proposed $7.25 billion fund, you must meet very specific eligibility criteria regarding your exposure to the product and your medical diagnosis. The settlement is uniquely designed to cover both people who are sick right now and people who may get sick in the future.

You may qualify as a member of this class if you meet the following conditions:

1. The Exposure Requirement

You must have been exposed to Roundup weedkiller prior to February 17, 2026. This exposure could happen in various ways. You do not need to be a commercial farmer or agricultural worker to qualify. Millions of Americans used Roundup to control weeds around their residential homes, gardens, and local commercial spaces.

2. The Medical Diagnosis Requirement

You must have a formal medical diagnosis of non-Hodgkin’s lymphoma (NHL). This settlement covers individuals who currently have the disease, as well as those who receive a diagnosis within the next 16 years.

This 16-year forward-looking window is a critical component of the agreement. Because cancer can take years or even decades to develop after toxic exposure, this provision ensures that people who get sick in the future still have a clear path to financial recovery.

Potential Payouts for Roundup Victims

If the court grants final approval to the settlement, eligible class members will receive financial compensation for their injuries. However, the payout is not a flat rate for every single person.

Individual settlement awards will likely range from $10,000 to $165,000.

The exact amount you receive will depend on several specific factors related to your case, including:

Extent of Exposure: How often you used Roundup, how long you used it, and whether you used it commercially or residentially.
Age at Diagnosis: Younger victims who developed cancer may receive higher payouts due to the longer impact on their lifespan and earning capacity.
Severity of Illness: The specific stage and progression of your non-Hodgkin’s lymphoma, as well as the intensity of the medical treatments you endured.

It is important to understand that class-action payouts often differ from the massive, multi-million-dollar verdicts you may have seen on the news from individual trials. While individual trials can result in huge punitive damages, they also carry the massive risk of losing and getting nothing. This settlement provides a guaranteed, structured payout without the uncertainty of a jury trial.

Bayer’s Stance on Liability and Cancer Risks

Despite agreeing to pay $7.25 billion, Bayer explicitly refuses to admit any liability or wrongdoing. The company continues to firmly maintain that glyphosate, the active ingredient in Roundup, does not cause cancer.

Bayer relies heavily on the stance of the U.S. Environmental Protection Agency (EPA), which has previously stated that glyphosate-based herbicides can be used safely and do not pose a cancer risk to humans.

However, many other global health authorities strongly disagree with the EPA. In 2015, the World Health Organization’s International Agency for Research on Cancer (IARC) reviewed the available scientific literature and classified glyphosate as “probably carcinogenic to humans.” This conflicting scientific perspective is the entire foundation of the Roundup litigation. By settling, Bayer aims to cap its financial losses and stop the bleeding from endless courtroom battles, even as it defends the safety of its flagship product.

Why You Need to Act Quickly: Important Deadlines

Preliminary approval is just the first step. The court still needs to grant final approval, and class members have the right to voice their opinions. You have major decisions to make, and the clock is already ticking.

The Option to Opt Out or Object

Not everyone agrees that this settlement is a good deal. In fact, attorneys from 14 other law firms representing nearly 20,000 potential class members filed a motion to intervene. They argued that the proposed release of liability for Monsanto is “breathtakingly broad” and gives the corporation everything it wants.

If you fall into the class definition, you will be officially notified. You then have until June 4, 2026, to decide your next move. You can:

Do nothing and stay in the class: You will be bound by the settlement terms and eligible for the payouts.
File an objection: You can formally tell the court why you believe the settlement is unfair.
Opt out entirely: This is a crucial right. If you opt out, you reject the settlement money, but you retain your legal right to file your own individual lawsuit against Bayer.

The Fairness Hearing

Judge Boyer will hold a formal fairness hearing on July 9, 2026. During this hearing, the judge will review all objections and decide whether the settlement is fair, reasonable, and adequate for the victims. If the judge grants final approval, the settlement goes into effect.

Currently, all Roundup-related lawsuits brought in Missouri by class members against Bayer are put on hold. Your case will stay paused unless you formally opt out of the agreement.

Making the Right Choice for Your Family

Deciding whether to accept a class-action settlement or opt out to pursue an individual lawsuit is incredibly complex. If your injuries are severe, your medical bills are towering, and your exposure was extreme, a $165,000 maximum payout might not cover your true damages. Conversely, opting out means you face the challenging, risky, and time-consuming process of taking a massive corporation to court on your own.

You should not make this decision without professional legal guidance. A lawyer can evaluate the specific details of your medical history and exposure to help you determine which path yields the best possible outcome for your future.

Contact Walch Law for a Free Consultation

A cancer diagnosis turns your world upside down. When that illness is caused by a chemical you thought was safe, the physical pain is compounded by anger and a deep sense of betrayal. You deserve accountability, and you deserve compensation that truly reflects what you have lost.

At Walch Law, we stand ready to help you navigate this complex legal turning point. We understand the science behind glyphosate exposure, the tactics used by massive agricultural corporations, and the nuances of class-action settlements.

Do not let the June 4 deadline pass without understanding your rights. If you or a loved one used Roundup and subsequently developed non-Hodgkin’s lymphoma, contact Walch Law today for a free, no-obligation consultation. We will listen to your story, review your options regarding the $7.25 billion settlement, and fight to secure the justice your family deserves.